NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 264 filers reported holding NOVOCURE LTD in Q2 2020. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | -100.0% | 2 | -99.9% | 0.00% | -100.0% |
| Q2 2021 | $368,000 | +119.0% | 1,657 | +30.0% | 0.02% | +88.9% |
| Q1 2021 | $168,000 | – | 1,275 | +127400.0% | 0.01% | – |
| Q4 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 1 | -99.7% | 0.00% | -100.0% |
| Q1 2020 | $22,000 | -82.0% | 320 | -77.9% | 0.00% | -71.4% |
| Q4 2019 | $122,000 | +154.2% | 1,446 | +126.3% | 0.01% | +133.3% |
| Q3 2019 | $48,000 | – | 639 | +21200.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 3 | -99.2% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 382 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | – | 382 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |